Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Transcat (TRNS) Cash & Equivalents (2019 - 2025)

Transcat (TRNS) has disclosed Cash & Equivalents for 13 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 25.19% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Dec 2025, down 25.19% year-over-year, with the annual reading at $1.5 million for FY2025, 92.28% down from the prior year.
  • Cash & Equivalents hit $3.5 million in Q4 2025 for Transcat, down from $5.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $35.2 million in Q4 2023 to a low of $254000.0 in Q2 2021.
  • Historically, Cash & Equivalents has averaged $6.7 million across 5 years, with a median of $2.0 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: surged 2109.98% in 2023 and later crashed 92.28% in 2025.
  • Year by year, Cash & Equivalents stood at $2.8 million in 2021, then crashed by 42.68% to $1.6 million in 2022, then soared by 2109.98% to $35.2 million in 2023, then plummeted by 86.82% to $4.6 million in 2024, then decreased by 25.19% to $3.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for TRNS at $3.5 million in Q4 2025, $5.1 million in Q3 2025, and $1.9 million in Q2 2025.